Latest Insider Transactions at Vertex Pharmaceuticals Inc (VRTX)
This section provides a real-time view of insider transactions for Vertex Pharmaceuticals Inc (VRTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of VERTEX PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of VERTEX PHARMACEUTICALS INC 's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 17
2023
|
Charles F Wagner Jr EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,000
-0.63%
|
$594,000
$297.51 P/Share
|
|
Mar 16
2023
|
Bastiano Sanna EVP, Cell & Genetic Therapies |
SELL
Open market or private sale
|
Direct |
2,746
-2.65%
|
$823,800
$300.81 P/Share
|
|
Mar 13
2023
|
Charles F Wagner Jr EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,666
-0.81%
|
$781,138
$293.54 P/Share
|
|
Mar 10
2023
|
Charles F Wagner Jr EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,088
-0.46%
|
$605,520
$290.69 P/Share
|
|
Feb 27
2023
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Open market or private sale
|
Direct |
354
-0.21%
|
$101,952
$288.27 P/Share
|
|
Feb 27
2023
|
Kristen Ambrose SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,207
-4.85%
|
$347,616
$288.52 P/Share
|
|
Feb 27
2023
|
Stuart A Arbuckle EVP, COO |
SELL
Open market or private sale
|
Direct |
5,034
-2.77%
|
$1,444,758
$287.89 P/Share
|
|
Feb 27
2023
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,238
-3.96%
|
$1,220,544
$288.52 P/Share
|
|
Feb 24
2023
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
3,308
-5.47%
|
$956,012
$289.12 P/Share
|
|
Feb 24
2023
|
Charles F Wagner Jr EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,308
-5.38%
|
$956,012
$289.12 P/Share
|
|
Feb 24
2023
|
Bastiano Sanna EVP, Cell & Genetic Therapies |
SELL
Payment of exercise price or tax liability
|
Direct |
3,970
-7.09%
|
$1,147,330
$289.12 P/Share
|
|
Feb 24
2023
|
Jeffrey M Leiden Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
13,730
-22.12%
|
$3,967,970
$289.12 P/Share
|
|
Feb 24
2023
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Payment of exercise price or tax liability
|
Direct |
2,468
-3.58%
|
$713,252
$289.12 P/Share
|
|
Feb 24
2023
|
Carmen Bozic EVP and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,308
-4.97%
|
$956,012
$289.12 P/Share
|
|
Feb 24
2023
|
Reshma Kewalramani CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
9,386
-6.74%
|
$2,712,554
$289.12 P/Share
|
|
Feb 24
2023
|
Kristen Ambrose SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
502
-5.57%
|
$145,078
$289.12 P/Share
|
|
Feb 24
2023
|
Stuart A Arbuckle EVP, COO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,714
-7.11%
|
$1,362,346
$289.12 P/Share
|
|
Feb 24
2023
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,970
-9.86%
|
$1,147,330
$289.12 P/Share
|
|
Feb 22
2023
|
Stuart A Arbuckle EVP, COO |
SELL
Open market or private sale
|
Direct |
2,401
-0.71%
|
$705,894
$294.14 P/Share
|
|
Feb 21
2023
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Open market or private sale
|
Direct |
480
-0.2%
|
$140,640
$293.11 P/Share
|
|
Feb 21
2023
|
Stuart A Arbuckle EVP, COO |
SELL
Open market or private sale
|
Direct |
2,402
-0.85%
|
$703,786
$293.02 P/Share
|
|
Feb 21
2023
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,002
-2.33%
|
$1,172,586
$293.13 P/Share
|
|
Feb 17
2023
|
Bastiano Sanna EVP, Cell & Genetic Therapies |
SELL
Payment of exercise price or tax liability
|
Direct |
3,750
-6.28%
|
$1,095,000
$292.85 P/Share
|
|
Feb 17
2023
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,498
-6.87%
|
$1,313,416
$292.85 P/Share
|
|
Feb 17
2023
|
Charles F Wagner Jr EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,750
-5.75%
|
$1,095,000
$292.85 P/Share
|
|
Feb 17
2023
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Payment of exercise price or tax liability
|
Direct |
3,498
-4.83%
|
$1,021,416
$292.85 P/Share
|
|
Feb 17
2023
|
Reshma Kewalramani CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
9,359
-6.29%
|
$2,732,828
$292.85 P/Share
|
|
Feb 17
2023
|
Stuart A Arbuckle EVP, COO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,498
-5.95%
|
$1,313,416
$292.85 P/Share
|
|
Feb 17
2023
|
Carmen Bozic EVP and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,750
-5.34%
|
$1,095,000
$292.85 P/Share
|
|
Feb 17
2023
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,750
-7.81%
|
$1,095,000
$292.85 P/Share
|
|
Feb 14
2023
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Open market or private sale
|
Direct |
320
-0.1%
|
$95,360
$298.11 P/Share
|
|
Feb 14
2023
|
Bastiano Sanna EVP, Cell & Genetic Therapies |
SELL
Open market or private sale
|
Direct |
2,181
-1.77%
|
$654,300
$300.7 P/Share
|
|
Feb 14
2023
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
6,398
-2.05%
|
$1,906,604
$298.47 P/Share
|
|
Feb 14
2023
|
Stuart A Arbuckle EVP, COO |
SELL
Open market or private sale
|
Direct |
6,398
-1.34%
|
$1,906,604
$298.49 P/Share
|
|
Feb 13
2023
|
Charles F Wagner Jr EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,992
-7.11%
|
$1,487,616
$298.26 P/Share
|
|
Feb 13
2023
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Open market or private sale
|
Direct |
275
-0.08%
|
$81,950
$298.72 P/Share
|
|
Feb 13
2023
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
2,995
-4.34%
|
$892,510
$298.26 P/Share
|
|
Feb 13
2023
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Payment of exercise price or tax liability
|
Direct |
4,657
-6.04%
|
$1,387,786
$298.26 P/Share
|
|
Feb 13
2023
|
Bastiano Sanna EVP, Cell & Genetic Therapies |
SELL
Open market or private sale
|
Direct |
113
-0.18%
|
$33,900
$300.39 P/Share
|
|
Feb 13
2023
|
Bastiano Sanna EVP, Cell & Genetic Therapies |
SELL
Payment of exercise price or tax liability
|
Direct |
4,340
-6.54%
|
$1,293,320
$298.26 P/Share
|
|
Feb 13
2023
|
Jeffrey M Leiden Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
13,344
-17.69%
|
$3,976,512
$298.26 P/Share
|
|
Feb 13
2023
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,798
-2.08%
|
$1,429,804
$298.63 P/Share
|
|
Feb 13
2023
|
David Altshuler EVP, Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,990
-9.19%
|
$1,785,020
$298.26 P/Share
|
|
Feb 13
2023
|
Stuart A Arbuckle EVP, COO |
SELL
Open market or private sale
|
Direct |
4,887
-1.43%
|
$1,456,326
$298.56 P/Share
|
|
Feb 13
2023
|
Stuart A Arbuckle EVP, COO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,990
-6.45%
|
$1,785,020
$298.26 P/Share
|
|
Feb 13
2023
|
Carmen Bozic EVP and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,992
-6.63%
|
$1,487,616
$298.26 P/Share
|
|
Feb 13
2023
|
Reshma Kewalramani CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
5,990
-3.87%
|
$1,785,020
$298.26 P/Share
|
|
Feb 10
2023
|
Charles F Wagner Jr EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,707
-3.71%
|
$795,858
$294.33 P/Share
|
|
Feb 10
2023
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,377
-1.96%
|
$404,838
$294.33 P/Share
|
|
Feb 10
2023
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
SELL
Payment of exercise price or tax liability
|
Direct |
2,611
-3.27%
|
$767,634
$294.33 P/Share
|